From Yahoo Finance: 2025-05-16 16:17:00

Back in May 2024, Jim Cramer expressed support for Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), a biotech company focusing on psychedelic treatments for mental health. Despite his optimism, the stock dropped by 22.97%. Mind Medicine Inc. is a clinical-stage biotech firm working on psychedelic-inspired treatments for mental health and addiction disorders. While MNMD shows potential for growth, some believe that other AI stocks offer higher returns with limited downside risk. For those interested in exploring AI stocks with 100x upside potential, check out the report on the cheapest AI stock. No disclosures were made.



Read more at Yahoo Finance: Was Jim Cramer Right About Mind Medicine (MNMD) Stock?